We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
Advice on the recognition, investigation and management of Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus (PVL-SA) cases.
Findings from a 2021 to 2022 incident response by the UK Health Security Agency (UKHSA) to Staphylococcus capitis in UK neonatal units.
Enhanced case protocol for close contacts of patients with Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus lower respiratory tract infections (LRTI).
The characteristics, diagnosis, management, surveillance and epidemiology of Panton-Valentine Leukocidin (PVL)-producing strains of Staphylococcus aureus.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
AMRHAI (antimicrobial resistance and healthcare associated infections) is the national reference unit for investigating AMR in healthcare-associated bacteria.
Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.
Reports presenting 30-day all-cause mortality following infection with healthcare-associated infections (HCAI).
Monthly counts of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia by organisation and location of onset (from April 2019).
The characteristics, diagnosis and management of impetigo.
The characteristics, diagnosis, treatment, and epidemiology of group B streptococci.
Annual counts and rates of meticillin resistant Staphylococcus aureus (MRSA) bacteraemia by acute trust and sub-integrated care board location (SICBL).
Counts of MRSA, MSSA, Gram-negative bacteraemia and C. difficile infection bi-annually reported by independent sector organisations, with accompanying commentary.
Trends in meticillin resistant (MRSA) and meticillin susceptible (MSSA) Staphylococcus aureus, Gram-negative bacteraemia and Clostridioides difficile infection.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.